These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17485687)

  • 1. Europe reconsidering DTCA.
    Meek C
    CMAJ; 2007 May; 176(10):1405. PubMed ID: 17485687
    [No Abstract]   [Full Text] [Related]  

  • 2. US Congress to consider limits on DTCA.
    Guthrie P
    CMAJ; 2007 May; 176(10):1404. PubMed ID: 17485685
    [No Abstract]   [Full Text] [Related]  

  • 3. EU health ministers reject proposal for limited direct to consumer advertising.
    Watson R
    BMJ; 2003 Jun; 326(7402):1284. PubMed ID: 12805139
    [No Abstract]   [Full Text] [Related]  

  • 4. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
    Toop L; Richards D; Saunders B
    N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
    [No Abstract]   [Full Text] [Related]  

  • 5. MEPs reject US-style direct advertising of drugs.
    Watson R;
    BMJ; 2002 Nov; 325(7371):990. PubMed ID: 12411353
    [No Abstract]   [Full Text] [Related]  

  • 6. European Commission may reform drug advertising legislation.
    Glass N
    Lancet; 2001 Jul; 358(9278):306. PubMed ID: 11498228
    [No Abstract]   [Full Text] [Related]  

  • 7. US aims to tighten rules on direct-to-consumer drug ads.
    Vastag B
    Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868
    [No Abstract]   [Full Text] [Related]  

  • 8. Reorienting the course of medicines policy: actions are bearing fruit.
    Prescrire Int; 2003 Oct; 12(67):192-4. PubMed ID: 14619908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmaceutical industry and disease mongering. Will industry's latest moves promote public health or private profit?
    McKechnie S
    BMJ; 2002 Jul; 325(7357):216; author reply 216. PubMed ID: 12143862
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efforts to ban direct-to-consumer advertising in New Zealand: a call to action.
    Hoffman JR; Cooper RJ
    Br J Gen Pract; 2003 Apr; 53(489):267-9. PubMed ID: 12879824
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct-to-consumer advertising--where does the public interest lie?
    Saunders B
    N Z Med J; 2003 Aug; 116(1180):U557; discussion U557. PubMed ID: 14581978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Will drug marketing help to turn patients to well-educated consumers?].
    Vuorenkoski L
    Duodecim; 2002; 118(10):979-80. PubMed ID: 12238005
    [No Abstract]   [Full Text] [Related]  

  • 14. New EU proposals ban communication of drug information through mass media.
    Watson R
    BMJ; 2011 Oct; 343():d6700. PubMed ID: 22016453
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct-to-consumer drug information in Europe.
    Ager B
    Lancet; 2007 Mar; 369(9564):822. PubMed ID: 17350444
    [No Abstract]   [Full Text] [Related]  

  • 16. Advertisement of medicines.
    Br Med J; 1961 May; 1(5237):1470-1. PubMed ID: 14447327
    [No Abstract]   [Full Text] [Related]  

  • 17. How to misinform patients.
    Drug Ther Bull; 2009 Aug; 47(8):85. PubMed ID: 19654416
    [No Abstract]   [Full Text] [Related]  

  • 18. From DTCA-PD to patient information to health information: the complex politics and semantics of EU health policy.
    Brooks E; Geyer R
    J Eval Clin Pract; 2012 Dec; 18(6):1235-40. PubMed ID: 22816868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns].
    Cianciara D
    Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Canadian approach to freedom of expression and the regulation of food and drug advertising.
    McNaughton EL; Goodridge CM
    Food Drug Law J; 2003; 58(3):521-36. PubMed ID: 14626988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.